ES2061463T3 - Compuestos de piperidina y su preparacion y uso. - Google Patents
Compuestos de piperidina y su preparacion y uso.Info
- Publication number
- ES2061463T3 ES2061463T3 ES87114648T ES87114648T ES2061463T3 ES 2061463 T3 ES2061463 T3 ES 2061463T3 ES 87114648 T ES87114648 T ES 87114648T ES 87114648 T ES87114648 T ES 87114648T ES 2061463 T3 ES2061463 T3 ES 2061463T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- piperidine compounds
- aralcoxi
- cicloalquilo
- alquilo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
NUEVOS COMPUESTOS DE PIPERIDINA QUE TIENEN LA ORMULA (I) DONDE R3 ES 3,4-METILENDIOXIFENILO, ARILO O ETEROARILO QUE SE SUSTITUYENOPCIONALMENTE CON UNO O MAS RUPOS DE C1-6 ALQUILO, C1-6 ALCOXI, C3-8 CICLOALQUILO, C3-5 LQUILENO O ARALCOXI. R1 ES C4-8 ALQUILO RECTO O RAMIFICADO, 1-8 ALCOXI-C4-8-ALQUILO, C4-7 CICLOALQUILO, RILOXI-C3-8-ALQUILO, C4-8-ALQUENILO O C4-8 CICLOALQUILO O 1 PUEDE TAMBIEN SER HIDROGENO O C1-3 ALQUILO CUANDO R3 ES RILO, QUE SE SUSTITUYE CON DOS OMAS DE C1-6 ALQUILO, C1-6 LCOXI, C3-8 CICLOALQUILO, ARALCOXI O CON C3-5 ALQUILENO; X S HIDROGENO O HALOGENO, Y DONDE Y ES O O S, Y UNA SAL DEL ISMO CON UNA SAL FARMACEUTICAMENTE ACEPTABLE. LOS NUEVOS OMPUETSOS SON UTILES EN EL TRATAMIETO DE LA ANOXIA, IGRAÑA, ISQUEMIA Y EPILEPSIA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK523286A DK523286D0 (da) | 1986-11-03 | 1986-11-03 | Piperidine forbindelser, deres fremstilling og anvendelse |
DK323487A DK323487D0 (da) | 1987-06-25 | 1987-06-25 | Piperidin forbindelser, deres fremstilling og anvendelse |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061463T3 true ES2061463T3 (es) | 1994-12-16 |
Family
ID=26066954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87114648T Expired - Lifetime ES2061463T3 (es) | 1986-11-03 | 1987-10-07 | Compuestos de piperidina y su preparacion y uso. |
Country Status (14)
Country | Link |
---|---|
US (3) | US4877799A (es) |
EP (1) | EP0266574B1 (es) |
JP (1) | JP2633872B2 (es) |
KR (1) | KR880006193A (es) |
AU (1) | AU602735B2 (es) |
CA (1) | CA1323367C (es) |
DE (1) | DE3788709T2 (es) |
ES (1) | ES2061463T3 (es) |
FI (1) | FI92821C (es) |
IE (1) | IE66332B1 (es) |
IL (1) | IL84021A (es) |
NZ (1) | NZ222155A (es) |
PH (1) | PH24749A (es) |
PT (1) | PT86066B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
DK231088D0 (da) * | 1988-04-28 | 1988-04-28 | Ferrosan As | Piperidinforbindelser, deres fremstilling og anvendelse |
US5017585A (en) * | 1986-11-03 | 1991-05-21 | Novo Nordisk A/S | Method of treating calcium overload |
AT391269B (de) * | 1988-12-30 | 1990-09-10 | Burghart Kurt | Pharmazeutische zubereitung |
DK640289D0 (da) * | 1989-12-18 | 1989-12-18 | Ferrosan As | Ny heterocyklisk kemi |
IL98757A (en) * | 1990-07-18 | 1997-01-10 | Novo Nordisk As | Piperidine derivatives their preparation and pharmaceutical compositions containing them |
GB9226111D0 (en) * | 1992-12-15 | 1993-02-10 | Smithkline Beecham Plc | Madicaments |
ES2102295B1 (es) * | 1994-03-18 | 1998-04-01 | Ferrer Int | Nuevos compuestos derivados de la n-benzoilmetil-piperidina. |
KR100502229B1 (ko) * | 1995-02-28 | 2005-11-08 | 다이이찌 산토리 파마 가부시키가이샤 | 아릴피페리딘및아릴피페라진유도체,및이를함유하는약제 |
WO1996036636A1 (en) * | 1995-05-17 | 1996-11-21 | Novo Nordisk A/S | Process for preparing 4-aryl-piperidine derivatives |
US6025355A (en) | 1997-05-19 | 2000-02-15 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
JP3446468B2 (ja) | 1996-04-15 | 2003-09-16 | 旭硝子株式会社 | ピペリジンカルビノール類の製造方法 |
JP3882224B2 (ja) | 1996-05-31 | 2007-02-14 | 旭硝子株式会社 | パロキセチンの製造方法 |
EP1394160A1 (en) * | 1996-06-13 | 2004-03-03 | SUMIKA FINE CHEMICALS Co., Ltd. | Process for preparing crystalline paroxetin hydrochloride |
AU710594B2 (en) | 1996-07-22 | 1999-09-23 | Asubio Pharma Co., Ltd. | Arylpiperidinol and arylpiperidine derivatives and pharmaceuticals containing the same |
WO1998003172A1 (fr) * | 1996-07-22 | 1998-01-29 | Suntory Limited | Derives arylpiperidinol et arylpiperidine et medicaments les contenant |
US6242198B1 (en) | 1996-07-25 | 2001-06-05 | Cambridge Neuroscience, Inc. | Methods of treatment of eye trauma and disorders |
US6756389B2 (en) | 1996-08-09 | 2004-06-29 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
US6110937A (en) * | 1997-04-03 | 2000-08-29 | Syntex Usa, Inc. | Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain |
ES2329739T3 (es) | 1997-04-07 | 2009-11-30 | Georgetown University | Analogos de cocaina. |
EP0994872B9 (en) * | 1997-06-10 | 2001-12-05 | Synthon B.V. | 4-phenylpiperidine compounds |
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
EP1318988A2 (en) | 2000-09-11 | 2003-06-18 | Sepracor, Inc. | Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
US6777554B2 (en) | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
CA2543089A1 (en) * | 2003-10-22 | 2005-05-12 | Georgetown University | Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications |
US20070142389A1 (en) * | 2005-12-20 | 2007-06-21 | Pfizer Inc. | Piperidine derivatives |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1203149A (en) * | 1968-06-10 | 1970-08-26 | Ici Ltd | Piperidine derivatives |
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
DE2549999A1 (de) * | 1975-11-07 | 1977-05-12 | Boehringer Mannheim Gmbh | Piperidin-derivate und verfahren zu ihrer herstellung |
DK149624C (da) * | 1983-03-07 | 1987-02-02 | Ferrosan As | Fremgangsmaade til fremstilling af (+)-trans-3-((4-methoxyphenoxy)-methyl)-1-methyl-4-phenylpiperidin eller et farmaceutisk acceptabelt salt heraf ud fra en blanding af enantiomererne |
US4585777A (en) * | 1984-02-07 | 1986-04-29 | A/S Ferrosan | (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT |
US4593036A (en) * | 1984-02-07 | 1986-06-03 | A/S Ferrosan | (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator |
GB8431478D0 (en) * | 1984-12-13 | 1985-01-23 | Beecham Group Plc | Compounds |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
-
1987
- 1987-09-23 IE IE256187A patent/IE66332B1/en not_active IP Right Cessation
- 1987-09-29 IL IL84021A patent/IL84021A/xx not_active IP Right Cessation
- 1987-10-07 EP EP87114648A patent/EP0266574B1/en not_active Expired - Lifetime
- 1987-10-07 ES ES87114648T patent/ES2061463T3/es not_active Expired - Lifetime
- 1987-10-07 DE DE87114648T patent/DE3788709T2/de not_active Expired - Fee Related
- 1987-10-08 US US07/106,154 patent/US4877799A/en not_active Expired - Fee Related
- 1987-10-09 FI FI874459A patent/FI92821C/fi not_active IP Right Cessation
- 1987-10-13 NZ NZ222155A patent/NZ222155A/xx unknown
- 1987-10-29 AU AU80482/87A patent/AU602735B2/en not_active Ceased
- 1987-11-02 CA CA000550834A patent/CA1323367C/en not_active Expired - Fee Related
- 1987-11-02 KR KR870012241A patent/KR880006193A/ko not_active Application Discontinuation
- 1987-11-02 JP JP62275915A patent/JP2633872B2/ja not_active Expired - Lifetime
- 1987-11-03 PT PT86066A patent/PT86066B/pt not_active IP Right Cessation
-
1989
- 1989-09-14 US US07/407,237 patent/US5019582A/en not_active Expired - Fee Related
- 1989-10-30 PH PH36012A patent/PH24749A/en unknown
-
1990
- 1990-02-28 US US07/486,252 patent/US4985446A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA1323367C (en) | 1993-10-19 |
FI874459A (fi) | 1988-05-04 |
IL84021A0 (en) | 1988-02-29 |
US4877799A (en) | 1989-10-31 |
EP0266574A3 (en) | 1988-07-20 |
NZ222155A (en) | 1990-08-28 |
US5019582A (en) | 1991-05-28 |
PT86066B (pt) | 1990-11-07 |
IE872561L (en) | 1988-05-03 |
EP0266574B1 (en) | 1994-01-05 |
IE66332B1 (en) | 1995-12-27 |
PH24749A (en) | 1990-10-01 |
AU8048287A (en) | 1988-05-05 |
JPS63126866A (ja) | 1988-05-30 |
FI92821B (fi) | 1994-09-30 |
FI874459A0 (fi) | 1987-10-09 |
US4985446A (en) | 1991-01-15 |
PT86066A (en) | 1987-12-01 |
EP0266574A2 (en) | 1988-05-11 |
KR880006193A (ko) | 1988-07-22 |
DE3788709D1 (de) | 1994-02-17 |
JP2633872B2 (ja) | 1997-07-23 |
AU602735B2 (en) | 1990-10-25 |
FI92821C (fi) | 1995-01-10 |
DE3788709T2 (de) | 1994-04-28 |
IL84021A (en) | 1993-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061463T3 (es) | Compuestos de piperidina y su preparacion y uso. | |
ATE184598T1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
ES2075082T3 (es) | Derivados de isoquinolina para el tratamiento del glaucoma o hipertension ocular. | |
ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
LU90976I2 (fr) | Sulfonamide sa préparation et son usage comme médicament et intermédiaire | |
AR246273A1 (es) | Sales de n, n'-(1-oxo-1,2-etanediil)-bis(acido aspartico y su uso en composiciones detergentes. | |
ES2096673T3 (es) | Uso de sulfonamidas como medicamentos y nuevas sulfonamidas. | |
FI935306A (fi) | Puhdistettujen, pintaa modifioivien aineiden käyttö estämään hiukkasten kasautumista steriloinnin aikana | |
ES2166379T3 (es) | 2-aminotetralinas sustituidas. | |
ATE258791T1 (de) | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen | |
ES2157252T3 (es) | Aplicacion del riluzol en el tratamiento del neuro-sida. | |
EA199700450A1 (ru) | Способы подавления миграции сосудистых гладкомышечных клеток | |
CO4920243A1 (es) | Bis-acridinas sustituidas y compuestos afines como ligandos del receptor ccrs, agentes antiinflamatorios y agentes antiviricos | |
ES2167544T3 (es) | Dioxidos de benzotiazina como antagonistas de la endotelina. | |
DE69321519T2 (de) | Pharmazeutische Anthocyanoside enthaltende Zusammensetzungen zur oralen Anwendung | |
ATE109001T1 (de) | Mittel zur stimulierung der tränensekretion. | |
DE69116705D1 (de) | Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
BE856124A (fr) | Fraction ovomucoide du blanc de l'oeuf de caille, ayant des proprietes therapeutiques vis-a-vis de l'allergie | |
ES2100689T3 (es) | Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2. | |
ES552232A0 (es) | Procedimiento para la obtencion de dihidropiridinas | |
ATE194282T1 (de) | L-arginin und analoge als thrombozytenaggregationshemmer | |
ATE59781T1 (de) | Potenzierung von prazosin. | |
FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 266574 Country of ref document: ES |